JP2014504598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014504598A5 JP2014504598A5 JP2013549933A JP2013549933A JP2014504598A5 JP 2014504598 A5 JP2014504598 A5 JP 2014504598A5 JP 2013549933 A JP2013549933 A JP 2013549933A JP 2013549933 A JP2013549933 A JP 2013549933A JP 2014504598 A5 JP2014504598 A5 JP 2014504598A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- cys
- disease
- peptide
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161434454P | 2011-01-20 | 2011-01-20 | |
| US61/434,454 | 2011-01-20 | ||
| US201161469138P | 2011-03-30 | 2011-03-30 | |
| US61/469,138 | 2011-03-30 | ||
| PCT/IL2012/000032 WO2012098546A2 (en) | 2011-01-20 | 2012-01-19 | Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014504598A JP2014504598A (ja) | 2014-02-24 |
| JP2014504598A5 true JP2014504598A5 (enExample) | 2015-03-05 |
| JP5943433B2 JP5943433B2 (ja) | 2016-07-05 |
Family
ID=45755445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013549933A Expired - Fee Related JP5943433B2 (ja) | 2011-01-20 | 2012-01-19 | 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8802635B2 (enExample) |
| EP (2) | EP2665742B1 (enExample) |
| JP (1) | JP5943433B2 (enExample) |
| CN (2) | CN103415532B (enExample) |
| AU (1) | AU2012208283B2 (enExample) |
| CA (1) | CA2825273A1 (enExample) |
| IN (1) | IN2013MN01582A (enExample) |
| WO (1) | WO2012098546A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2879019A1 (en) * | 2012-07-23 | 2014-01-30 | Oneday - Biotech And Pharma Ltd. | Glutathione-elevating compositions and uses thereof |
| EP2877194A4 (en) | 2012-07-25 | 2016-03-16 | Oneday Biotech And Pharma Ltd | Compositions and methods for increasing carnitine concentration in muscle tissue |
| CN103467569B (zh) * | 2013-08-10 | 2015-05-20 | 李�昊 | 一种抗菌止痒消炎消肿去疤痕的短肽及其应用 |
| LT3066089T (lt) | 2013-11-08 | 2020-02-25 | Promentis Pharmaceuticals, Inc. | Pakeistieji n-acetil-l-cisteino dariniai ir giminingi junginiai |
| EP3077049B1 (en) * | 2013-12-02 | 2019-06-19 | Stealth BioTherapeutics Corp | Compositions for use in treating vitiligo |
| WO2015118546A1 (en) * | 2014-02-10 | 2015-08-13 | Oneday - Biotech And Pharma Ltd. | Mucolytic compositions and uses thereof |
| US9464111B2 (en) * | 2014-06-26 | 2016-10-11 | L'oreal | Short peptides and a method of use as an antioxidant |
| EP3177265B1 (en) * | 2014-08-05 | 2022-04-13 | Amantin Experts | Protective skin compositions |
| JP6533723B2 (ja) * | 2015-09-11 | 2019-06-19 | キユーピー株式会社 | 抗酸化剤 |
| CN105254714B (zh) * | 2015-10-16 | 2019-09-10 | 中国农业大学 | 一种源自酪蛋白的抗氧化肽及应用 |
| CN106432014B (zh) * | 2016-09-05 | 2019-08-16 | 中国医学科学院放射医学研究所 | 胺基硫醇类化合物及其制备方法和其在辐射防护中的应用 |
| CN106749525B (zh) * | 2016-12-07 | 2020-01-07 | 南京财经大学 | 一种小肽及其应用 |
| KR101943081B1 (ko) * | 2017-08-31 | 2019-01-29 | (주)케어젠 | 주름 개선 활성을 나타내는 펩타이드 및 이의 용도 |
| KR102293250B1 (ko) * | 2017-09-18 | 2021-08-26 | 애니젠 주식회사 | 활성물질-헥사펩타이드 복합체 및 이를 포함하는 화장료 조성물 |
| CN108484738B (zh) * | 2018-03-28 | 2022-03-15 | 中国人民解放军军事科学院军事医学研究院 | 辐抗肽突变蛋白及其制备与纯化方法 |
| WO2021230393A1 (ko) * | 2020-05-12 | 2021-11-18 | 주식회사 카인사이언스 | 염증성 피부질환 치료용 펩타이드 및 이의 용도 |
| CN112608966B (zh) * | 2020-12-31 | 2023-05-23 | 华南理工大学 | 一种超声辅助矿物质螯合杏仁肽及其制备方法和应用 |
| CN114041603A (zh) * | 2021-11-09 | 2022-02-15 | 中国农业大学 | 肽-锌螯合物在抗过敏产品中的应用 |
| CN120302959A (zh) * | 2022-07-13 | 2025-07-11 | 欧莱雅 | 修饰肽、组合物、抑制肌肉细胞收缩的方法、改善皮肤的方法和修饰肽的用途 |
| CN115920014A (zh) * | 2022-12-08 | 2023-04-07 | 酵之美生物科技(绍兴)有限责任公司 | 硫氧还蛋白的模拟肽的一种治疗炎症性肠病的用途 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| IL109943A (en) | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
| WO2002064091A2 (en) * | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US5985261A (en) * | 1996-06-28 | 1999-11-16 | National Jewish Medical And Research Center | Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage |
| US5928926A (en) * | 1996-07-01 | 1999-07-27 | Research Development Foundation | Isolation and cloning of the human ARSA-I gene and uses thereof |
| US6369106B1 (en) | 1996-12-26 | 2002-04-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Treatment of ischemic brain injuries with brain targeted anti oxidant compounds |
| US5874468A (en) | 1996-12-26 | 1999-02-23 | Yissum | Brain targeted low molecular weight hydrophobic antioxidant compounds |
| US5889055A (en) | 1997-04-04 | 1999-03-30 | Howard; James R. | L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism |
| US6627746B1 (en) * | 1998-04-17 | 2003-09-30 | Exelixis, Inc. | Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof |
| WO1999062927A1 (en) | 1998-06-05 | 1999-12-09 | Human Genome Sciences, Inc. | Connective tissue growth factor-4 |
| US8252309B2 (en) | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
| GB2368339B (en) * | 2000-10-26 | 2002-09-18 | Yissum Res Dev Co | Complex incorporating a plurality of antioxidants |
| US20030109457A1 (en) * | 2001-10-25 | 2003-06-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| GB0108491D0 (en) * | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| AU2003234146A1 (en) | 2002-04-22 | 2003-11-03 | Experimental And Applied Sciences, Inc. | Food supplements containing 4-hydroxyisoleucine and creatine |
| JP2006513147A (ja) | 2002-09-10 | 2006-04-20 | ナショナル ジューイッシュ メディカル アンド リサーチ センター | 粘液または痰の液化のための生成物および処理 |
| US7361747B2 (en) * | 2003-05-22 | 2008-04-22 | The University Of Hong Kong | Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus |
| EP1634083A2 (en) * | 2003-06-17 | 2006-03-15 | VIB vzw | Peptide combos and their uses |
| ITRM20040066A1 (it) * | 2004-02-09 | 2004-05-09 | Consiglio Nazionale Ricerche | Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. |
| WO2005123108A2 (en) | 2004-06-09 | 2005-12-29 | William Feinstein | Advanced vitamins and protein based nutritional supplements |
| WO2007002372A2 (en) * | 2005-06-24 | 2007-01-04 | Regents Of The University Of Minnesota | Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| WO2007144979A1 (ja) * | 2006-06-12 | 2007-12-21 | Vexon, Inc. | ペプチド誘導体 |
| US7713937B2 (en) * | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| US20090285912A1 (en) | 2008-05-16 | 2009-11-19 | Ramiro Rodriquez | Food Supplement and Method for Enhancing Athletic Performance |
| US20110318380A1 (en) | 2008-10-01 | 2011-12-29 | Dako Denmark A/S | MHC Multimers in Cancer Vaccines and Immune Monitoring |
| CA2879019A1 (en) | 2012-07-23 | 2014-01-30 | Oneday - Biotech And Pharma Ltd. | Glutathione-elevating compositions and uses thereof |
| EP2877194A4 (en) | 2012-07-25 | 2016-03-16 | Oneday Biotech And Pharma Ltd | Compositions and methods for increasing carnitine concentration in muscle tissue |
-
2012
- 2012-01-19 CN CN201280012667.2A patent/CN103415532B/zh not_active Expired - Fee Related
- 2012-01-19 EP EP12705459.1A patent/EP2665742B1/en not_active Not-in-force
- 2012-01-19 JP JP2013549933A patent/JP5943433B2/ja not_active Expired - Fee Related
- 2012-01-19 IN IN1582MUN2013 patent/IN2013MN01582A/en unknown
- 2012-01-19 EP EP16162206.3A patent/EP3121189A1/en not_active Withdrawn
- 2012-01-19 WO PCT/IL2012/000032 patent/WO2012098546A2/en not_active Ceased
- 2012-01-19 AU AU2012208283A patent/AU2012208283B2/en not_active Ceased
- 2012-01-19 CA CA2825273A patent/CA2825273A1/en not_active Abandoned
- 2012-01-19 CN CN201610237509.7A patent/CN105837659A/zh active Pending
-
2013
- 2013-08-09 US US13/963,537 patent/US8802635B2/en not_active Expired - Fee Related
-
2014
- 2014-07-03 US US14/323,576 patent/US9034824B2/en not_active Expired - Fee Related
-
2015
- 2015-04-21 US US14/692,476 patent/US9617301B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014504598A5 (enExample) | ||
| CY1123749T1 (el) | Μεθοδοι μειωσης του κινδυνου καρδιαγγειακου γεγονοτος σε ενα υποκειμενο επι θεραπειας στατινης χρησιμοποιωντας αιθυλ εστερα εικοσαπενταενοϊκου οξεος | |
| ES2613606T3 (es) | Uso de derivados de ácidos grasos polinsaturados como medicamentos | |
| CY1122628T1 (el) | Χρηση αιθυλεστερα εικοσαπενταενοϊκου οξεος για θεραπεια υπερτριγλυκεριδαιμιας | |
| HK1204272A1 (en) | Methods of treating pediatric metabolic syndrome | |
| NZ596386A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| MX355035B (es) | Composición de uridina y citidina para uso en la prevención o tratamiento de neurotrauma. | |
| JP2013515742A5 (enExample) | ||
| NZ709083A (en) | Eicosapentaenoic acid (epa) formulations | |
| CY1122809T1 (el) | Εστερικα προ-φαρμακα της [3-(1-(1η-ιμιδαζολ-4-υλ)αιθυλο)-2-μεθυλοφαινυλο) μεθανολης για τη θεραπεια οφθαλμικων νοσηματων | |
| IN2012DN00407A (enExample) | ||
| HRP20160203T1 (hr) | Pripravci koji sadrže 15-hepe i postupci njihove upotrebe | |
| WO2017077528A3 (en) | Methods and pharmaceutical compositions for treatment of lung inflammation | |
| Bazan | Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis nl of the anti-inflammatory and anti-apoptotic neuroprotectin D1 | |
| MY145985A (en) | Dha esters and use thereof in treatment and prevention of cardiovascular disease | |
| JP2019513752A5 (enExample) | ||
| JP2019052168A (ja) | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ | |
| Rambharose et al. | Novel dendritic derivatives of unsaturated fatty acids as promising transdermal permeation enhancers for tenofovir | |
| MX2011008261A (es) | FORMULACIONES FARMACEUTICAS DE PEPTIDOS INHIBIDORES DE TGF-ß1. | |
| JP2017523230A5 (enExample) | ||
| JP2010522146A5 (enExample) | ||
| FR2981932B1 (fr) | Nouveaux esters de derives n-acyles d'acides amines et de diols, procede pour leur preparation, et utilisation en cosmetique et comme medicament | |
| JP2016501248A5 (enExample) | ||
| WO2014193652A3 (en) | Novel n-3 immunoresolvents: structures and actions | |
| WO2011143271A3 (en) | Therapeutic liposomes and methods for producing and using the same |